Approval · Notice of Compliance 9634 · 2008
HUMALOG: Notice of Compliance 9634
Issued June 18, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9634
- Date
- June 18, 2008
- Company
- Eli Lilly Canada IncToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New manufacturing site
- Therapeutic class
- Antidiabetic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HUMALOG | Not yet assigned | — |
| HUMALOG CARTRIDGE | Not yet assigned | — |
| HUMALOG PEN | Not yet assigned | — |
| HUMALOG MIX 25 (CARTRIDGE) | Not yet assigned | — |
| HUMALOG MIX 25 (PEN) | Not yet assigned | — |
| HUMALOG MIX 25 (VIAL) | Not yet assigned | — |
| HUMALOG MIX 50 (CARTRIDGE) | Not yet assigned | — |
| HUMALOG MIX 50 (PEN) | Not yet assigned | — |
| HUMALOG MIX 50 (VIAL) | Not yet assigned | — |
Medicinal ingredients
- INSULIN LISPRO 100 UNIT per ML
- INSULIN LISPRO 25 UNIT per ML
- INSULIN LISPRO PROTAMINE SUSPENSION 75 UNIT per ML
- INSULIN LISPRO 50 UNIT per ML
- INSULIN LISPRO PROTAMINE SUSPENSION 50 UNIT per ML